vs
Side-by-side financial comparison of Federal Realty Investment Trust (FRT) and iRhythm Holdings, Inc. (IRTC). Click either name above to swap in a different company.
Federal Realty Investment Trust is the larger business by last-quarter revenue ($336.0M vs $208.9M, roughly 1.6× iRhythm Holdings, Inc.). Federal Realty Investment Trust runs the higher net margin — 38.6% vs 2.7%, a 35.9% gap on every dollar of revenue. On growth, iRhythm Holdings, Inc. posted the faster year-over-year revenue change (27.1% vs 8.7%). Over the past eight quarters, iRhythm Holdings, Inc.'s revenue compounded faster (25.8% CAGR vs 6.5%).
Federal Realty Investment Trust is a real estate investment trust that invests in shopping centers in the Northeastern United States, the Mid-Atlantic states, California, and South Florida.
iRhythm Holdings is a digital healthcare company focused on cardiac care, developing and commercializing wearable ambulatory heart monitoring devices paired with AI-powered analytical tools. It primarily serves healthcare providers and patients across the United States, helping to detect undiagnosed arrhythmias such as atrial fibrillation through convenient long-term heart rhythm tracking that delivers actionable clinical insights.
FRT vs IRTC — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $336.0M | $208.9M |
| Net Profit | $129.7M | $5.6M |
| Gross Margin | — | 70.9% |
| Operating Margin | 53.8% | 1.1% |
| Net Margin | 38.6% | 2.7% |
| Revenue YoY | 8.7% | 27.1% |
| Net Profit YoY | 103.5% | 518.5% |
| EPS (diluted) | $1.49 | $0.18 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $336.0M | — | ||
| Q4 25 | $336.0M | $208.9M | ||
| Q3 25 | $322.3M | $192.9M | ||
| Q2 25 | $311.5M | $186.7M | ||
| Q1 25 | $309.2M | $158.7M | ||
| Q4 24 | $311.4M | $164.3M | ||
| Q3 24 | $303.6M | $147.5M | ||
| Q2 24 | $296.1M | $148.0M |
| Q1 26 | $129.7M | — | ||
| Q4 25 | $129.7M | $5.6M | ||
| Q3 25 | $61.6M | $-5.2M | ||
| Q2 25 | $155.9M | $-14.2M | ||
| Q1 25 | $63.8M | $-30.7M | ||
| Q4 24 | $65.5M | $-1.3M | ||
| Q3 24 | $61.0M | $-46.2M | ||
| Q2 24 | $112.0M | $-20.1M |
| Q1 26 | — | — | ||
| Q4 25 | — | 70.9% | ||
| Q3 25 | — | 71.1% | ||
| Q2 25 | — | 71.2% | ||
| Q1 25 | — | 68.8% | ||
| Q4 24 | — | 70.0% | ||
| Q3 24 | — | 68.8% | ||
| Q2 24 | — | 69.9% |
| Q1 26 | 53.8% | — | ||
| Q4 25 | 53.8% | 1.1% | ||
| Q3 25 | 34.3% | -4.4% | ||
| Q2 25 | 65.1% | -10.0% | ||
| Q1 25 | 35.0% | -20.5% | ||
| Q4 24 | 35.1% | -2.5% | ||
| Q3 24 | 34.9% | -34.1% | ||
| Q2 24 | 53.0% | -15.5% |
| Q1 26 | 38.6% | — | ||
| Q4 25 | 38.6% | 2.7% | ||
| Q3 25 | 19.1% | -2.7% | ||
| Q2 25 | 50.0% | -7.6% | ||
| Q1 25 | 20.6% | -19.3% | ||
| Q4 24 | 21.0% | -0.8% | ||
| Q3 24 | 20.1% | -31.3% | ||
| Q2 24 | 37.8% | -13.6% |
| Q1 26 | $1.49 | — | ||
| Q4 25 | $1.49 | $0.18 | ||
| Q3 25 | $0.69 | $-0.16 | ||
| Q2 25 | $1.78 | $-0.44 | ||
| Q1 25 | $0.72 | $-0.97 | ||
| Q4 24 | $0.74 | $-0.03 | ||
| Q3 24 | $0.70 | $-1.48 | ||
| Q2 24 | $1.32 | $-0.65 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $107.4M | $583.8M |
| Total DebtLower is stronger | $5.0B | — |
| Stockholders' EquityBook value | $3.2B | $152.7M |
| Total Assets | $9.1B | $1.0B |
| Debt / EquityLower = less leverage | 1.53× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $107.4M | — | ||
| Q4 25 | $107.4M | $583.8M | ||
| Q3 25 | $111.3M | $565.2M | ||
| Q2 25 | $177.0M | $545.5M | ||
| Q1 25 | $109.2M | $520.6M | ||
| Q4 24 | $123.4M | $535.6M | ||
| Q3 24 | $97.0M | $522.0M | ||
| Q2 24 | $103.2M | $561.5M |
| Q1 26 | $5.0B | — | ||
| Q4 25 | $5.0B | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $4.5B | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | $3.2B | — | ||
| Q4 25 | $3.2B | $152.7M | ||
| Q3 25 | $3.2B | $121.9M | ||
| Q2 25 | $3.2B | $103.7M | ||
| Q1 25 | $3.2B | $86.7M | ||
| Q4 24 | $3.2B | $90.9M | ||
| Q3 24 | $3.1B | $71.8M | ||
| Q2 24 | $3.0B | $99.2M |
| Q1 26 | $9.1B | — | ||
| Q4 25 | $9.1B | $1.0B | ||
| Q3 25 | $8.9B | $995.2M | ||
| Q2 25 | $8.6B | $964.0M | ||
| Q1 25 | $8.6B | $926.1M | ||
| Q4 24 | $8.5B | $931.4M | ||
| Q3 24 | $8.5B | $909.7M | ||
| Q2 24 | $8.4B | $919.2M |
| Q1 26 | 1.53× | — | ||
| Q4 25 | 1.53× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 1.42× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $26.2M |
| Free Cash FlowOCF − Capex | — | $14.5M |
| FCF MarginFCF / Revenue | — | 6.9% |
| Capex IntensityCapex / Revenue | — | 5.6% |
| Cash ConversionOCF / Net Profit | — | 4.70× |
| TTM Free Cash FlowTrailing 4 quarters | — | $34.5M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $622.4M | $26.2M | ||
| Q3 25 | $147.8M | $34.9M | ||
| Q2 25 | $150.7M | $27.7M | ||
| Q1 25 | $179.0M | $-7.9M | ||
| Q4 24 | $574.6M | $19.2M | ||
| Q3 24 | $144.1M | $24.3M | ||
| Q2 24 | $169.7M | $11.8M |
| Q1 26 | — | — | ||
| Q4 25 | — | $14.5M | ||
| Q3 25 | — | $20.1M | ||
| Q2 25 | — | $17.3M | ||
| Q1 25 | — | $-17.3M | ||
| Q4 24 | — | $12.4M | ||
| Q3 24 | — | $15.5M | ||
| Q2 24 | — | $3.4M |
| Q1 26 | — | — | ||
| Q4 25 | — | 6.9% | ||
| Q3 25 | — | 10.4% | ||
| Q2 25 | — | 9.3% | ||
| Q1 25 | — | -10.9% | ||
| Q4 24 | — | 7.5% | ||
| Q3 24 | — | 10.5% | ||
| Q2 24 | — | 2.3% |
| Q1 26 | — | — | ||
| Q4 25 | — | 5.6% | ||
| Q3 25 | — | 7.7% | ||
| Q2 25 | — | 5.6% | ||
| Q1 25 | — | 5.9% | ||
| Q4 24 | — | 4.2% | ||
| Q3 24 | — | 6.0% | ||
| Q2 24 | — | 5.7% |
| Q1 26 | — | — | ||
| Q4 25 | 4.80× | 4.70× | ||
| Q3 25 | 2.40× | — | ||
| Q2 25 | 0.97× | — | ||
| Q1 25 | 2.81× | — | ||
| Q4 24 | 8.77× | — | ||
| Q3 24 | 2.36× | — | ||
| Q2 24 | 1.52× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FRT
Segment breakdown not available.
IRTC
| Commercial Payors | $111.7M | 53% |
| Centers For Medicare And Medicaid | $49.2M | 24% |
| Healthcare Institutions | $34.3M | 16% |
| Non Contracted Third Party Payors | $13.7M | 7% |
